Skip To Main Content

Artikkelit

Järjestä

Suodattimet

Nollaa
  • Terapia-alue

Breaking the Barrier: How to Manage Hypoglycaemia Fear in Diabetes Care

EFLUELDA - korkea-annoksinen influenssarokote

FLUNITY-HD : the largest individually randomised influenza vaccine effectiveness study of its kind.

FLUNITY-HD is the largest individually randomised influenza vaccine effectiveness study, with nearly half a million older adults across multiple seasons.1

Cumulative Life Course Impairment (CLCI) in Atopic Dermatitis

Deliver-T (RWE Study): New Findings on Toujeo® for T2D Management Following Dual GIP/GLP-1 RA Therapy

Psychological Considerations During Insulin Product Changes

Understanding the psychological burden of switching insulin. Discover ways to cope and support patient well-being during treatment changes.

Recognizing the Urgency to proactively plan a switch: Managing Timely Insulin Transitions for Continuity of Care

Learn why timely insulin transitions are critical for patient safety and continuity of care. Act early to avoid gaps and risks.

Understanding Gaucher Disease: Symptoms, Classification, and Clinical Presentation

Gaucher disease is a lysosomal storage disorder caused by a pathogenic variant in the gene responsible for producing the enzyme acid β-glucosidase. More than 300 alleles carrying pathogenic variants have already been identified.1

The story of the Beta Cells and their role in autoimmune Type 1 Diabetes

Diagnostic and confirmation testing

Gaucher disease is rare and has signs and symptoms that can be confused with those of many other diseases. However, some tests allow the definitive diagnosis of the disease.

Understanding Gaucher Disease: Genetics, Transmission, and Family Screening

Diagnostic Algorithm